The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling. — المؤلف: Andrikopoulos, Petros — Journal of the American Society of Nephrology : JASN 20191108
- المؤلف
- Andrikopoulos, Petros
- النشر
- Journal of the American Society of Nephrology : JASN 20191108
- الوصف
- 33-49 p.
- الموضوعات
- Animals؛ Biopsy, Needle؛ Cells, Cultured؛ Disease Models, Animal؛ Extracellular Signal-Regulated MAP Kinases؛ Fibroblasts؛ Fibrosis؛ Immunohistochemistry